Monoclonal Antibody Protection Against Pseudomonas aeruginosa

  • R. E. W. Hancock
Conference paper
Part of the Bayer-Symposium book series (BAYER-SYMP, volume 8)


Biotechnology companies are isolating monoclonal antibodies against various bacterial products with the aim of utilizing them in prevention and therapy of infection. One that has received attention is the anti-lipid A monoclones for all gram-negative bacteria. Unfortunately, the early results have been quite disappointing. Our investigation was to see if some outer membrane proteins which are functionally conserved were also antigenically conserved and would provide a candidate antigen for a vaccine.


Monoclonal Antibody Bacterial Product Outer Membrane Protein Clonal Antibody Protective Antigen 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Springer-Verlag Berlin Heidelberg 1985

Authors and Affiliations

  • R. E. W. Hancock

There are no affiliations available

Personalised recommendations